Stay updated on Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Sign up to get notified when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.

Latest updates to the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a consolidated Locations section with state-level site listings (California, Illinois, Kansas, Massachusetts, Michigan, Missouri, New York, Texas, Wisconsin) and updated the page revision from v3.3.2 to v3.3.3. The old per-state location headings were removed.SummaryDifference1.0%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedSite revision updated from v3.2.0 to v3.3.2 (v3.3.2 added, v3.2.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedA government funding/operating status notice was removed from the page. This change affects only contextual messaging and does not alter the study details or eligibility information.SummaryDifference0.3%

- Check64 days agoChange DetectedKRYSTAL 2 (NCT04330664) is now shown as Completed. Enrollment is listed as 86 and the last update posted date is 2025-04-04.SummaryDifference0.4%

- Check93 days agoChange Detected- Updated the page to include a government-operating-status notice and a new release version (v3.2.0). - Removed the previous version tag (v3.1.0).SummaryDifference5%

- Check100 days agoChange DetectedVersion label updated from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.